@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix mgi: . @prefix geneProductOf: . @prefix schem: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: mgi:1859152; a Protein: . sub:_2 occursIn: species:10090; rdf:object schem:Lysophosphatidylcholines; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(MGI:Pla2g6) -> a(SCHEM:Lysophosphatidylcholines)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "1.4" . sub:_3 prov:value "Pla2g6 does not require Ca for catalysis Pla2g6 generates lysophosphatidylcholine acceptors for arachidonic acid incorporation into phosphatidylcholine has been proposed because Pla2g6 inhibition reduces lysophosphatidylcholine levels and suppresses arachidonate incorporation and phsopholipid remodeling"; prov:wasQuotedFrom pubmed:10318801 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:10318801; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:29:47.050+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }